AGIOS PHARMACEUTICALS, INC. (AGIO) Stock Profile — Insider Trades & Financials

Revenue$20.0M

Net Income-$108.0M

EPS$-7.12

Market Cap$2.1B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Brian Goff

CEO & Executive Director

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Employees: 536
Headquarters: CAMBRIDGE, MA, United States
Website: www.agios.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-9.06%

ROA?

-8.33%

D/E Ratio?

0.09

Op. Margin?

-608.89%

📊

Profitability Ratios

Net Margin?

-541.09%

Loading company sections...

AGIOS PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness